Position in LGND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$237,713,585
+$123,278,799 QoQ
Shares Held
752,044
+31.2% QoQ
Ownership
3.77%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#8
of 413 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. LGND ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
This page
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in LGND
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,713,585 | 752,044 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $114,434,786 | 573,177 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $93,808,970 | 496,160 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $40,716,690 | 229,856 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,155,733 | 186,099 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $19,593,574 | 186,357 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,865,822 | 185,402 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,474,418 | 94,659 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $1,321,701 | 15,686 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,018,940 | 13,939 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,004,592 | 14,066 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $816,587 | 13,628 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $680,406 | 9,437 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $202,973 | 2,275 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $289,323 | 2,572 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $392,481 | 2,541 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $327,260 | 2,349 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $204,392 | 1,558 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $222,270 | 1,458 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||